Results 21 to 30 of about 123,872 (261)
National Journal of Physiology, Pharmacy and Pharmacology, 2020 Background: Beta-blockers with additional beneficial activity such as beta-2 agonist and alpha-1 blocking activity are developed and available as the third-generation beta-blockers for effective management of hypertension with comorbid conditions ...
Haripriya Sadam, Subash K R
doaj +1 more source
Beta adrenergic blockers poisoning [PDF]
ABC: časopis urgentne medicine, 2016 AIM: To demonstrate the basic characteristics in terms of clinical features and a basic method of treatment in β-adrenergic blockers poisoning. MATERIALS AND METHODS: Review of the available literature, the protocols of departments that participated in ...
Tadić Milorad, Stanimirović Marijana
doaj
The place of metoprolol tartrate in the treatment of cardiovascular diseases
Медицинский совет, 2016 Since the beginning of the 1960s, beta-blockers have been number one medications in the treatment of cardiovascular diseases. A number of randomized controlled trials (RCTs) demonstrated positive effect of beta-blockers on morbidity and mortality [1]. It
N. V. Romanova, I. V. Zhirov
doaj +1 more source
Antihypertensive Drug Use and the Risk of Depression: A Systematic Review and Network Meta-analysis
Frontiers in Pharmacology, 2021 Background: Although numerous cohort studies have reported an association between antihypertensives use and depression, the exact effect of antihypertensives on depression remains unclear.Objective: To clarify the association between antihypertensives ...
Ying Li +5 more
doaj +1 more source
Molecules, 2022 Beta-blockers are antihypertensive drugs and can be abused by athletes in some sport competitions; it is therefore necessary to monitor beta-blocker levels in biological samples.
Aliya Nur Hasanah +2 more
doaj +1 more source
Medical Journal of Babylon, 2021 Background: There is controversy about the role of beta-blockers in the number of acute exacerbations in patients with chronic obstructive pulmonary disease (COPD).
Hemin Khalid Saber
doaj +1 more source
Beta blockers and their combinations in the management of hypertension
South African Family Practice, 2012 Beta blockers have been prescribed for the treatment of primary hypertension for a very long time. Currently, it is doubtful whether this is still a good idea. In fact, many are of the opinion that beta blockers should be relegated to a fourth-line drug,
J.A. Ker
doaj +1 more source
Reciprocal control of viral infection and phosphoinositide dynamics
FEBS Letters, EarlyView.Phosphoinositides, although scarce, regulate key cellular processes, including membrane dynamics and signaling. Viruses exploit these lipids to support their entry, replication, assembly, and egress. The central role of phosphoinositides in infection highlights phosphoinositide metabolism as a promising antiviral target.
Marie Déborah Bancilhon, Bruno Mesmin
wiley +1 more source
Use of Beta-Blockers as a First-Line Treatment for Primary Hypertension
HeartsBackground: Even though beta-blockers had been used as a first-line therapy for hypertension, since the late 1960s, the Eighth Joint National Committee, JNC 8, decided to recommend them no longer.
Maryam Izadi +2 more
doaj +1 more source
Self-reported and actual beta-blocker prescribing for heart failure patients: physician predictors.
PLoS ONE, 2009 BackgroundBeta-blockers reduce mortality among patients with systolic heart failure (HF), yet primary care provider prescription rates remain low.ObjectiveTo examine the association between primary care physician characteristics and both self-reported ...
Sanjai Sinha +3 more
doaj +1 more source